BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 19272641)

  • 1. The urokinase plasminogen activator (uPA) system in uterine natural killer cells in the placental bed during early pregnancy.
    Naruse K; Lash GE; Bulmer JN; Innes BA; Otun HA; Searle RF; Robson SC
    Placenta; 2009 May; 30(5):398-404. PubMed ID: 19272641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of extravillous trophoblast invasion by uterine natural killer cells is dependent on gestational age.
    Lash GE; Otun HA; Innes BA; Percival K; Searle RF; Robson SC; Bulmer JN
    Hum Reprod; 2010 May; 25(5):1137-45. PubMed ID: 20219775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitors for MMPs (TIMPs) in uterine natural killer cells in early human pregnancy.
    Naruse K; Lash GE; Innes BA; Otun HA; Searle RF; Robson SC; Bulmer JN
    Hum Reprod; 2009 Mar; 24(3):553-61. PubMed ID: 19088110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and function of the urokinase type plasminogen activator during mouse hemochorial placental development.
    Teesalu T; Blasi F; Talarico D
    Dev Dyn; 1998 Sep; 213(1):27-38. PubMed ID: 9733098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low oxygen concentrations inhibit trophoblast cell invasion from early gestation placental explants via alterations in levels of the urokinase plasminogen activator system.
    Lash GE; Otun HA; Innes BA; Bulmer JN; Searle RF; Robson SC
    Biol Reprod; 2006 Feb; 74(2):403-9. PubMed ID: 16251495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization and significance of urokinase plasminogen activator and its receptor in placental tissue from intrauterine, ectopic and molar pregnancies.
    Floridon C; Nielsen O; Holund B; Sunde L; Westergaard JG; Thomsen SG; Teisner B
    Placenta; 1999 Nov; 20(8):711-21. PubMed ID: 10527826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of urokinase, plasminogen activator inhibitors and urokinase receptor in pregnant rhesus monkey uterus during early placentation.
    Feng Q; Liu Y; Liu K; Byrne S; Liu G; Wang X; Li Z; Ockleford CD
    Placenta; 2000; 21(2-3):184-93. PubMed ID: 10736241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of interleukin 8 in uterine natural killer cell regulation of extravillous trophoblast cell invasion.
    De Oliveira LG; Lash GE; Murray-Dunning C; Bulmer JN; Innes BA; Searle RF; Sass N; Robson SC
    Placenta; 2010 Jul; 31(7):595-601. PubMed ID: 20483454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R; Schaaf A
    Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle.
    Nordengren J; Pilka R; Noskova V; Ehinger A; Domanski H; Andersson C; Høyer-Hansen G; Hansson SR; Casslén B
    Mol Hum Reprod; 2004 Sep; 10(9):655-63. PubMed ID: 15243126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen activators and inhibitors are transcribed during early macaque implantation.
    Feng Q; Liu K; Liu YX; Byrne S; Ockleford CD
    Placenta; 2001; 22(2-3):186-99. PubMed ID: 11170823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of tumour necrosis factor-α in combination with interferon-γ on first trimester extravillous trophoblast invasion.
    Otun HA; Lash GE; Innes BA; Bulmer JN; Naruse K; Hannon T; Searle RF; Robson SC
    J Reprod Immunol; 2011 Jan; 88(1):1-11. PubMed ID: 21112094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
    Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progestin inhibits and thrombin stimulates the plasminogen activator/inhibitor system in term decidual stromal cells: implications for parturition.
    Norwitz ER; Snegovskikh V; Schatz F; Foyouzi N; Rahman M; Buchwalder L; Lee HJ; Funai EF; Buhimschi CS; Buhimschi IA; Lockwood CJ
    Am J Obstet Gynecol; 2007 Apr; 196(4):382.e1-8. PubMed ID: 17403427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deflazacort modulates the fibrinolytic pattern and reduces uPA-dependent chemioinvasion and proliferation in rheumatoid arthritis synoviocytes.
    Del Rosso A; Cinelli M; Guiducci S; Pignone A; Fibbi G; Margheri F; Gabrielli A; Giacomelli R; Coppini A; Del Rosso M; Matucci Cerinic M
    Rheumatology (Oxford); 2005 Oct; 44(10):1255-62. PubMed ID: 15998634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and plasminogen activator inhibitors in patients with renal cell carcinoma: correlation with tumor associated macrophage and prognosis.
    Ohba K; Miyata Y; Kanda S; Koga S; Hayashi T; Kanetake H
    J Urol; 2005 Aug; 174(2):461-5. PubMed ID: 16006865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. uPA and uPAR contribute to NK cell invasion through the extracellular matrix.
    Al-Atrash G; Kitson RP; Xue Y; Mazar AP; Kim MH; Goldfarb RH
    Anticancer Res; 2001; 21(3B):1697-704. PubMed ID: 11497249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal synthesis of urokinase type-plasminogen activator, its receptor, and plasminogen activator inhibitor-1 in diabetic nephropathy in rats: modulation by angiotensin-converting-enzyme inhibitor.
    Kenichi M; Masanobu M; Takehiko K; Shoko T; Akira F; Katsushige A; Takashi H; Yoshiyuki O; Shigeru K
    J Lab Clin Med; 2004 Aug; 144(2):69-77. PubMed ID: 15322501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The urokinase plasminogen activator system: a rich source of tumour markers for the individualised management of patients with cancer.
    Duffy MJ; Duggan C
    Clin Biochem; 2004 Jul; 37(7):541-8. PubMed ID: 15234235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and localization of the urokinase-type plasminogen activator receptor (uPAR) in the human placenta.
    Nishida Y; Hayashi Y; Imai Y; Itoh H
    Kobe J Med Sci; 1998 Feb; 44(1):31-43. PubMed ID: 9846056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.